Year: 2014
Type: article
Abstract: There is currently a need for imaging methods capable of detecting cell death in tissues and the early onset of tumor cell death resulting from therapy. However, to date, no probe has been approved for routine imaging of cell death in the clinic. The challenge is to identify hallmarks of cell death, which have clinical relevance, and then to develop and validate imaging biomarkers for these hallmarks. We focus here on cell death imaging probes, which either have been trialed in the clinic or have significant promise, based on preclinical studies.
Source: Journal of Nuclear Medicine
Authors: André A. Neves, Kevin M. Brindle
Institutions: Cancer Research UK Cambridge Center, University of Cambridge
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funder: Cancer Research UK
Awards: G2761709219, G4077235876, G5357398350
OpenAlex ID: W2102554917
